Heather L Hampel
Overview
Explore the profile of Heather L Hampel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veney D, Wei L, Toland A, Presley C, Hampel H, Padamsee T, et al.
Cancer Med
. 2024 Sep;
13(17):e70095.
PMID: 39258462
Introduction: Tumor genomic testing (TGT) is standard-of-care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was...
2.
Ten Broeke S, van der Klift H, Tops C, Aretz S, Bernstein I, Buchanan D, et al.
J Clin Oncol
. 2018 Aug;
36(29):2961-2968.
PMID: 30161022
Purpose: Lynch syndrome due to pathogenic variants in the DNA mismatch repair genes MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial cancer, although extracolonic cancers have been...
3.
Robson M, Bradbury A, Arun B, Domchek S, Ford J, Hampel H, et al.
J Clin Oncol
. 2015 Sep;
33(31):3660-7.
PMID: 26324357
The American Society of Clinical Oncology (ASCO) has long affirmed that the recognition and management of individuals with an inherited susceptibility to cancer are core elements of oncology care. ASCO...
4.
Foley S, Rios J, Mgbemena V, Robinson L, Hampel H, Toland A, et al.
EBioMedicine
. 2015 May;
2(1):74-81.
PMID: 26023681
Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on members...
5.
Syngal S, Brand R, Church J, Giardiello F, Hampel H, Burt R
Am J Gastroenterol
. 2015 Feb;
110(2):223-62.
PMID: 25645574
This guideline presents recommendations for the management of patients with hereditary gastrointestinal cancer syndromes. The initial assessment is the collection of a family history of cancers and premalignant gastrointestinal conditions...
6.
Gregory Feero W, Facio F, Glogowski E, Hampel H, Stopfer J, Eidem H, et al.
Genet Med
. 2014 Dec;
17(9):753-6.
PMID: 25521335
Purpose: This study examines the analytic validity of a software tool designed to provide individuals with risk assessments for colorectal cancer based on personal health and family history information. The...
7.
Salipante S, Scroggins S, Hampel H, Turner E, Pritchard C
Clin Chem
. 2014 Jul;
60(9):1192-9.
PMID: 24987110
Background: Microsatellite instability (MSI) is a useful phenotype in cancer diagnosis and prognosis. Nevertheless, methods to detect MSI status from next generation DNA sequencing (NGS) data are underdeveloped. Methods: We...
8.
Beamer L, Grant M, Espenschied C, Blazer K, Hampel H, Weitzel J, et al.
J Clin Oncol
. 2012 Feb;
30(10):1058-63.
PMID: 22355048
Purpose: Immunohistochemistry (IHC) for MLH1, MSH2, MSH6, and PMS2 protein expression and microsatellite instability (MSI) are well-established tools to screen for Lynch syndrome (LS). Although many cancer centers have adopted...
9.
Palomaki G, McClain M, Melillo S, Hampel H, Thibodeau S
Genet Med
. 2009 Jan;
11(1):42-65.
PMID: 19125127
No abstract available.
10.
Chen H, Taylor N, Sotamaa K, Mutch D, Powell M, Schmidt A, et al.
Int J Cancer
. 2007 Jan;
120(8):1684-8.
PMID: 17230510
Epigenetic silencing of MLH1 is the most common cause of defective DNA mismatch repair in endometrial and colorectal cancers. We hypothesized that variation in the MLH1 gene might contribute to...